Key facts
- Amplifi Vascular’s last known valuation is $37.0M (Nov 2024).
- It has raised $24.0M; the latest was Early Stage VC ($17.0M) in Jan 2025.
- Notable investors include BioGenerator Ventures.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Amplifi Vascular
- ·The full record, as it builds
Funding rounds
No funding rounds for Amplifi Vascular are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Amplifi Vascular
Developer of endovascular medical devices designed for the treatment of neurovascular and peripheral vascular diseases. The company develops immediate occlusion and rapid sealing of cerebral aneurysms and other target vessel segments using an over-the-wire microcatheter system, enabling healthcare professionals to improve procedural efficiency, reduce complications, and enhance patient outcomes in vascular interventions.
- Sector
- Healthcare
- HQ
- Chesterfield, MO, United States
- Founded
- 2023
- Employees
- 9
- Website
- amplifivascular.com/
- Ownership
- Privately Held (backing)
Amplifi Vascular doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Amplifi Vascular shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Amplifi Vascular in its N-PORT filings yet. We sweep new filings monthly.